why choose us

First received: March 06, 2023

Clinical Trial: Prophylactic Methylergonovine for Twin Cesarean

Study Status: Completed

Recruit Status: RECRUITING

Condition: Twin; Complicating Pregnancy

Study Type: INTERVENTIONAL


Official Title: Prophylactic Methylergonovine in Patients Undergoing Cesarean Delivery With Twin Gestations: A Randomized Controlled Trial

Brief Summary: Obstetrical hemorrhage (excessive bleeding related to pregnancy) is a leading cause of maternal morbidity (disease or symptom of disease) and mortality (death) worldwide with a significantly higher frequency and severity following cesarean delivery.Twin gestations (twin pregnancy) are at particularly higher risk for postpartum hemorrhage, yet the management of obstetrical bleeding following twin delivery remains identical to singleton delivery.The purpose of this study is to understand the effect of prophylactic…

Read more